Sep 29

SS 36 - Predicting Benefit and Toxicity: Biomarkers in Prostate Radiotherapy

313 - Digital Pathology-Based Multimodal Artificial Intelligence Biomarker Validation In Patients with High and Very High Risk Localized Prostate Cancer from the POP-RT Trial

04:05pm - 04:15pm ET

Presenter(s)

Vedang Murthy, MD - Tata Memorial Centre, New Mumbai, Maharashtra